The role of genetic polymorphisms of glutation-S-transferase μ1 (GSTM1) and gelatinase B (MMP9) in the risk of COPD development Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD Year: 2003
Metabolic gene polymorphisms (CYP1A1, EPHX1, GSTM1 and GSTP1) associations with the severity of cystic fibfosis airway disease Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003
Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma Source: Eur Respir J 2004; 24: Suppl. 48, 136s Year: 2004
The effect of polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) on lung cancer outcome Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003
Polymorphisms of some metabolic (GSTM1, GSTT1) and cytokine (IL-4, IL-4Ra) genes in pregnant women affected by asthma Source: Eur Respir J 2005; 26: Suppl. 49, 617s Year: 2005
Detoxifying enzymes genes (EPHX1, CYP1A1 and GSTP1) genotypes and risk of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 196s Year: 2003
Matrix metalloproteinase (MMP ) -1 and -3 promoter polymorphisms in Bulgarian patients with COPD Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
The influence of polymorphism of GSTT1 ,GSTM1, ACE genes on the development of BA in children Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009
The leucocyte telomere length, GSTM1 and GSTT1 null genotypes and the risk of COPD Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
P53 protein expression and polymorphism of GSTT1 and GSTM1 genes in central lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006
Dependence of stage of severity of chronic obstructive pulmonary disease on metalloproteinase 1, 12, surfactant protein C, microsomal epoxid hydrolase gene polymorphisms Source: Eur Respir J 2006; 28: Suppl. 50, 523s Year: 2006
Genetic polymorphisms CYP1A1 m1 , GSTM1 , GSTT1 null and lung cancer susceptibility in a Brazilian population Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006
Genes of detoxication system, matrix metalloproteinase 9 (MMP9) and set of group factors of blood in the risk of development of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 63s Year: 2004
Are ADAM33, TNF, LTA, EPHX1 and ADRB2 polymorphisms (SNPs) associated with COPD in a large case-control study when cases and controls are purified? Source: Eur Respir J 2007; 30: Suppl. 51, 131s Year: 2007
The influence of cigarette smoke on the polymorphism of matrix metalloprotease (MMP2) in asthmatic patients Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
The role of GSTT1 and GSTM1 in the risk of bronchial asthma (BA) formation in early kids, born by BA females Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008
The influence of the polymorphism at codon 72 of exon 4 of the P53 gene and GSTM1 and GSTT1 null in lung cancer risk in a Brazilian population Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006
Cystic fibrosis(CF) severity and polymorphisms(pol) in ACE, GCLC and GST(M1, T1 and P1) genes Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010
MMP2 -1306C>T polymorphism and the enzyme plasma levels in patients with COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015